Singular Genomics Systems (OMIC) - Margin resik

Logo grafis Singular Genomics Systems Inc (OMIC)

Singular Genomics Systems (OMIC) operates on an independent product cycle, establishing the company as a defensive asset. The relative net sales profit on this chart visualizes this stability, where -3237.90 represents the current level of the indicator. However, geopolitical tensions and sanctions could impact raw material supplies. These risks are mitigated by outsourcing electronics assembly and logistics to third-party contractors.

Rentabilitas dodolan miturut bathi resik Singular Genomics Corp (OMIC): kanggo periode 04.07.2022 - 01.03.2025

Rincian analitis lan laporan data perusahaan Singular Genomics Corp (OMIC)

Analisis kabeh metrik perusahaan:Singular Genomics, OMIC
Barang unggulan Singular Genomics Systems Inc

Investors use this indicator to evaluate the efficiency of converting revenue into net income. The metric is calculated as the ratio of net profit to total sales volume. By analyzing the net profit margin, one can determine the real value of every dollar earned. For Singular Genomics Systems (OMIC), this figure reflects the return on the implementation of G4 systems. Synergy with scientific institutes directly impacts the business's final margins.

Karo sapa Singular Genomics Systems saingan

TEM: Margin dodolan resik|Tingkat bathi miturut bathi resik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Margin dodolan resik|Repligen Inc. - Margin bathi resik|Margin dodolan resik RNA|CRSP - Margin resik|GeneDx - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik RARE|Beam Tx - Margin dodolan resik|SRPT - Margin dodolan resik|TWST (Twist Bio) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik TXG|Rentabilitas dodolan miturut bathi resik NTLA|Stoke Therapeutics Inc (STOK) - Margin dodolan perusahaan|Margin dodolan resik BLFS|Margin resik WVE (Wave Life Sciences Corp)|Margin resik Maze Therapeutics MAZE|Tingkat bathi resik SION|PRME - Margin resik|Margin dodolan perusahaan Taysha TSHA|QURE: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik MeiraGTx PLC|RGNX (REGENXBIO Inc) - Margin dodolan resik|solidbio.com (SLDB) - Margin dodolan perusahaan|Margin resik Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Rentabilitas dodolan resik|Benitec Biopharma - Rentabilitas dodolan miturut bathi resik|DSGN: Rentabilitas dodolan resik|RCKT: Rentabilitas dodolan miturut bathi resik|FDMT - Margin dodolan resik|LXEO: Margin dodolan resik|Korro Bio Inc. - Tingkat bathi resik|EDIT (editasmedicine.com) - Margin dodolan resik|Margin resik SLN|Margin resik ProQR Therapeutics NV (PRQR)|Codexis - Rentabilitas dodolan resik|Margin resik Sangamo SGMO|NAUT: Rentabilitas dodolan resik|MGX: Rentabilitas dodolan miturut bathi resik|Margin resik Precision BioSciences|GBIO (generationbio.com) - Rentabilitas dodolan miturut bathi resik|Margin resik boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Margin dodolan resik|Rentabilitas dodolan resik IMNN (Imunon, Inc.)|Margin dodolan resik PHIO|MBIO - Margin resik|Margin dodolan resik RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Margin resik|Applied DNA - Margin dodolan resik|Margin resik Bluebird Bio|ImmunoPrecise (IPA) - Margin resik|Margin bathi resik OMGA (Omega)|RGLS (Regulus Therapeutics, Inc.) - Margin dodolan resik|SYRS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX